Connection
Jennifer Goldman to Trimethoprim
This is a "connection" page, showing publications Jennifer Goldman has written about Trimethoprim.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.837 |
|
|
|
-
Tessman RT, Nolte W, Toren P, Gibson K, Vu L, Goldman J. Simultaneous quantification of trimethoprim metabolites in pediatric plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 May 15; 1198:123232.
Score: 0.813
-
Goldman JL, van Haandel L. Trimethoprim: The overlooked component of trimethoprim-sulfamethoxazole idiosyncratic adverse drug reactions. Pharmacoepidemiol Drug Saf. 2018 08; 27(8):949-951.
Score: 0.623
-
Goldman JL, Koen YM, Rogers SA, Li K, Leeder JS, Hanzlik RP. Bioactivation of Trimethoprim to Protein-Reactive Metabolites in Human Liver Microsomes. Drug Metab Dispos. 2016 10; 44(10):1603-7.
Score: 0.548
-
Goldman JL, Leeder JS, Van Haandel L, Pearce RE. In Vitro Hepatic Oxidative Biotransformation of Trimethoprim. Drug Metab Dispos. 2015 Sep; 43(9):1372-80.
Score: 0.509
-
Feldman K, Suppes SL, Goldman JL. Clarification of adverse drug reactions by a pharmacovigilance team results in increased antibiotic re-prescribing at a freestanding United States children's hospital. PLoS One. 2024; 19(1):e0295410.
Score: 0.230
-
van Haandel L, Goldman JL, Pearce RE, Leeder JS. Urinary biomarkers of trimethoprim bioactivation in vivo following therapeutic dosing in children. Chem Res Toxicol. 2014 Feb 17; 27(2):211-8.
Score: 0.115